Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NPPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TRAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KHDRBS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOPC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEG9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC100653137 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRYGB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDGFRP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
AGRN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGF2BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTSF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHB13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC645321 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on